FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

385112003: Conventional release cutaneous powder (dose form)

Status: current, Defined. Date: 31-Jan 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1479374014 Cutaneous powder en Synonym Active Case insensitive SNOMED CT core
3559622012 Conventional release cutaneous powder (dose form) en Fully specified name Active Case insensitive SNOMED CT core
3559623019 Conventional release cutaneous powder en Synonym Active Case insensitive SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Cutaneous powder Is a Cutaneous AND/OR transdermal dosage form false Inferred relationship Some
Cutaneous powder Is a Drug powder false Inferred relationship Some
Cutaneous powder Is a Cutaneous dose form true Inferred relationship Some
Cutaneous powder Has dose form administration method Apply true Inferred relationship Some
Cutaneous powder Has dose form intended site Cutaneous true Inferred relationship Some
Cutaneous powder Has dose form release characteristic Conventional release true Inferred relationship Some
Cutaneous powder Has basic dose form Powder true Inferred relationship Some
Cutaneous powder Has dose form transformation No transformation true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Calcium carbonate 900 mg/g cutaneous powder Has manufactured dose form True Cutaneous powder Inferred relationship Some
Calcium undecylenate 100 mg/g cutaneous powder Has manufactured dose form True Cutaneous powder Inferred relationship Some
Povidone iodine 50 mg/g cutaneous powder Has manufactured dose form True Cutaneous powder Inferred relationship Some
Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder Has manufactured dose form True Cutaneous powder Inferred relationship Some
Zinc undecylenate 100 mg/g cutaneous powder Has manufactured dose form True Cutaneous powder Inferred relationship Some
Cutaneous powder spray Is a False Cutaneous powder Inferred relationship Some
Nystatin 100 unit/mg cutaneous powder Has manufactured dose form True Cutaneous powder Inferred relationship Some
Streptokinase+streptodornase 100,000/25,000units topical powder Has manufactured dose form False Cutaneous powder Inferred relationship Some
Chlorhexidine hydrochloride 2.5 mg/g and tolnaftate 10 mg/g cutaneous powder Has manufactured dose form True Cutaneous powder Inferred relationship Some
Undecylenic acid 50 microgram/mg and zinc undecylenate 200 microgram/mg cutaneous powder Has manufactured dose form True Cutaneous powder Inferred relationship Some
Tolnaftate 10 mg/g cutaneous powder Has manufactured dose form True Cutaneous powder Inferred relationship Some
Mafenide acetate 5% powder Has manufactured dose form False Cutaneous powder Inferred relationship Some
Chlorhexidine diacetate 10 mg/g cutaneous powder Has manufactured dose form True Cutaneous powder Inferred relationship Some
Clotrimazole 10 mg/g cutaneous powder Has manufactured dose form True Cutaneous powder Inferred relationship Some
Salicylic acid+boric acid 3%/5% conventional release cutaneous powder Has manufactured dose form False Cutaneous powder Inferred relationship Some
Salicylic acid 50 microgram/mg and zinc oxide 200 microgram/mg cutaneous powder Has manufactured dose form True Cutaneous powder Inferred relationship Some
Miconazole nitrate 20 mg/g cutaneous powder Has manufactured dose form True Cutaneous powder Inferred relationship Some

Reference Sets

Dose based prescribing dose form reference set

Qualifier value foundation reference set

Medication form reference set

Back to Start